ARTICLE | Company News
Allergan, ForSight Vision5 deal
August 22, 2016 7:00 AM UTC
Allergan acquired ForSight Vision5 for $95 million in cash and an undisclosed milestone tied to the launch of ForSight’s Helios ocular insert. The insert, which delivers bimatoprost, a prostaglandin ...